Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD)

ClinicalTrials.gov ID: NCT00268216

Public ClinicalTrials.gov record NCT00268216. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 2:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled Study to Investigate the Long-term Effects of Salmeterol/Fluticasone Propionate (Seretide tm) 50/500mcg BD, Salmeterol 50mcg BD and Fluticasone Propionate 500mcg BD, All Delivered Via the Diskus tm/Accuhaler tm Inhaler, on Mortality and Morbidity of Subjects With Chronic Obstructive Pulmonary Disease (COPD) Over 3 Years of Treatment

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to see if fluticasone 500mcg/salmeterol 50mcg can improve the survival of subjects with COPD and also assess the long term safety profile of this drug.

Study identification

NCT ID
NCT00268216
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
6,228 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2000 (Type not available)
Primary completion
Nov 2005 (Actual)
Completion
Nov 2005 (Actual)
Last update posted
Jan 20, 2017

2000 – 2005

United States locations

U.S. sites
190
U.S. states
42
U.S. cities
155
Facility City State ZIP Site status
GSK Investigational Site Birmingham Alabama 35235 —
GSK Investigational Site Birmingham Alabama 35294-7340 —
GSK Investigational Site Birmingham Alabama 35294 —
GSK Investigational Site Jasper Alabama 35501 —
GSK Investigational Site Mobile Alabama 36608 —
GSK Investigational Site Ozark Alabama 36360 —
GSK Investigational Site Phoenix Arizona 85006 —
GSK Investigational Site Phoenix Arizona 85008 —
GSK Investigational Site Scottsdale Arizona 85251 —
GSK Investigational Site Berkeley California 94705 —
GSK Investigational Site Burbank California 91505 —
GSK Investigational Site Encinitas California 92024 —
GSK Investigational Site Fresno California 93710 —
GSK Investigational Site Fullerton California 92835 —
GSK Investigational Site Long Beach California 90822 —
GSK Investigational Site Los Angeles California 90033 —
GSK Investigational Site Los Angeles California 90048 —
GSK Investigational Site Rancho Mirage California 92270 —
GSK Investigational Site Riverside California 92506 —
GSK Investigational Site San Diego California 92103-6204 —
GSK Investigational Site San Diego California 92103 —
GSK Investigational Site San Diego California 92117 —
GSK Investigational Site San Diego California 92120 —
GSK Investigational Site San Diego California 92123 —
GSK Investigational Site San Francisco California 94102 —
GSK Investigational Site San Luis Obispo California 93401 —
GSK Investigational Site Sepuldeva California 91343 —
GSK Investigational Site Stockton California 95207 —
GSK Investigational Site Sunnyvale California 94086 —
GSK Investigational Site Sylmar California 91342-1495 —
GSK Investigational Site Vista California 92083 —
GSK Investigational Site Walnut Creek California 94598 —
GSK Investigational Site Arvada Colorado 80002 —
GSK Investigational Site Denver Colorado 80206 —
GSK Investigational Site Denver Colorado 80218 —
GSK Investigational Site Fort Collins Colorado 80528 —
GSK Investigational Site Longmont Colorado 80501 —
GSK Investigational Site Loveland Colorado 80538 —
GSK Investigational Site Pueblo Colorado 81001 —
GSK Investigational Site Wheat Ridge Colorado 80033 —
GSK Investigational Site Hartford Connecticut 06105 —
GSK Investigational Site Stamford Connecticut 06902 —
GSK Investigational Site Altamonte Springs Florida 32701 —
GSK Investigational Site Atlantis Florida 33462 —
GSK Investigational Site Bay Pines Florida 33744 —
GSK Investigational Site Brandon Florida 33511 —
GSK Investigational Site Clearwater Florida 33756 —
GSK Investigational Site Fort Lauderdale Florida 33316 —
GSK Investigational Site Jacksonville Florida 32205 —
GSK Investigational Site Jacksonville Florida 32216 —
GSK Investigational Site Largo Florida 33770 —
GSK Investigational Site Longwood Florida 32779 —
GSK Investigational Site Loxahatchee Groves Florida 33470 —
GSK Investigational Site Miami Florida 33136 —
GSK Investigational Site Pace Florida 32571 —
GSK Investigational Site Palm Springs Florida 33461 —
GSK Investigational Site Pensacola Florida 32514 —
GSK Investigational Site Sarasota Florida 34239 —
GSK Investigational Site Tamarac Florida 33321 —
GSK Investigational Site Tampa Florida 33613 —
GSK Investigational Site West Palm Beach Florida 33409 —
GSK Investigational Site Zephyrhills Florida 33540 —
GSK Investigational Site Atlanta Georgia 30342 —
GSK Investigational Site Augusta Georgia 30901 —
GSK Investigational Site Blue Ridge Georgia 30513 —
GSK Investigational Site Decatur Georgia 30033 —
GSK Investigational Site Marietta Georgia 30066 —
GSK Investigational Site Rome Georgia 30165 —
GSK Investigational Site Roswell Georgia 30076 —
GSK Investigational Site Coeur d'Alene Idaho 83814 —
GSK Investigational Site Champaign Illinois 61821 —
GSK Investigational Site Chicago Illinois 60612-3824 —
GSK Investigational Site Chicago Illinois 60612-7323 —
GSK Investigational Site Hines Illinois 60141-5099 —
GSK Investigational Site North Chicago Illinois 60064 —
GSK Investigational Site Peoria Illinois 61602 —
GSK Investigational Site South Bend Indiana 46617 —
GSK Investigational Site Dubuque Iowa 52001 —
GSK Investigational Site Wichita Kansas 67207 —
GSK Investigational Site Wichita Kansas 67208 —
GSK Investigational Site Lexington Kentucky 40536 —
GSK Investigational Site Louisville Kentucky 40215 —
GSK Investigational Site Lafayette Louisiana 70503 —
GSK Investigational Site Shreveport Louisiana 71103 —
GSK Investigational Site Sunset Louisiana 70584 —
GSK Investigational Site Auburn Maine 04210 —
GSK Investigational Site Baltimore Maryland 21204 —
GSK Investigational Site Baltimore Maryland 21224 —
GSK Investigational Site Boston Massachusetts 02135 —
GSK Investigational Site Swansea Massachusetts 02777 —
GSK Investigational Site Cadillac Michigan 49601 —
GSK Investigational Site Livonia Michigan 48152 —
GSK Investigational Site Saint Joseph Michigan 49085 —
GSK Investigational Site Traverse City Michigan 49684 —
GSK Investigational Site Edina Minnesota 55438 —
GSK Investigational Site Minneapolis Minnesota 55417 —
GSK Investigational Site Jackson Mississippi 39202 —
GSK Investigational Site Chesterfield Missouri 63017 —
GSK Investigational Site Jefferson City Missouri 65109 —
GSK Investigational Site Kansas City Missouri 64108 —
GSK Investigational Site Saint Charles Missouri 63301 —
GSK Investigational Site St Louis Missouri 63110 —
GSK Investigational Site St Louis Missouri 63141 —
GSK Investigational Site Billings Montana 59102 —
GSK Investigational Site Omaha Nebraska 68105 —
GSK Investigational Site Omaha Nebraska 68124 —
GSK Investigational Site Omaha Nebraska 68134 —
GSK Investigational Site Omaha Nebraska 68198-2456 —
GSK Investigational Site Omaha Nebraska 68198 —
GSK Investigational Site Las Vegas Nevada 89104 —
GSK Investigational Site Gilford New Hampshire 3249 —
GSK Investigational Site Lebanon New Hampshire 03756 —
GSK Investigational Site East Orange New Jersey 07018 —
GSK Investigational Site New Brunswick New Jersey 8901 —
GSK Investigational Site Newark New Jersey 07112 —
GSK Investigational Site Summit New Jersey 07091 —
GSK Investigational Site Trenton New Jersey 8629 —
GSK Investigational Site Albuquerque New Mexico 87108 —
GSK Investigational Site Albany New York 12205 —
GSK Investigational Site Albany New York 12208 —
GSK Investigational Site Bronxville New York 10708 —
GSK Investigational Site Brooklyn New York 11217 —
GSK Investigational Site Buffalo New York 14221 —
GSK Investigational Site Great Neck New York 11023 —
GSK Investigational Site Mineola New York 11501 —
GSK Investigational Site New York New York 10011 —
GSK Investigational Site New York New York 10016 —
GSK Investigational Site New York New York 10025 —
GSK Investigational Site New York New York 10029 —
GSK Investigational Site Chapel Hill North Carolina 27514 —
GSK Investigational Site Charlotte North Carolina 28207 —
GSK Investigational Site Elizabeth City North Carolina 27909 —
GSK Investigational Site Greenville North Carolina 27834 —
GSK Investigational Site High Point North Carolina 27262 —
GSK Investigational Site Wilmington North Carolina 28401 —
GSK Investigational Site Winston-Salem North Carolina 27103 —
GSK Investigational Site Winston-Salem North Carolina 27157 —
GSK Investigational Site Cincinnati Ohio 45219 —
GSK Investigational Site Cincinnati Ohio 45267-0405 —
GSK Investigational Site Cleveland Ohio 44024 —
GSK Investigational Site Franklin Ohio 45005 —
GSK Investigational Site Toledo Ohio 43614-5809 —
GSK Investigational Site Toledo Ohio 43617 —
GSK Investigational Site Oklahoma City Oklahoma 73104 —
GSK Investigational Site Lake Oswego Oregon 97035 —
GSK Investigational Site Medford Oregon 97504 —
GSK Investigational Site Portland Oregon 97213-2281 —
GSK Investigational Site Portland Oregon 97213 —
GSK Investigational Site Allentown Pennsylvania 18104 —
GSK Investigational Site Downington Pennsylvania 19335 —
GSK Investigational Site Doylestown Pennsylvania 8901 —
GSK Investigational Site Erie Pennsylvania 16508 —
GSK Investigational Site Philadelphia Pennsylvania 19129 —
GSK Investigational Site Philadelphia Pennsylvania 19140 —
GSK Investigational Site Philadelphia Pennsylvania 19148 —
GSK Investigational Site Pittsburgh Pennsylvania 15213 —
GSK Investigational Site Pittsburgh Pennsylvania 15218 —
GSK Investigational Site Ridley Park Pennsylvania 19078 —
GSK Investigational Site Cranston Rhode Island 02920 —
GSK Investigational Site East Providence Rhode Island 02914 —
GSK Investigational Site Charleston South Carolina 29403 —
GSK Investigational Site Charleston South Carolina 29406-7108 —
GSK Investigational Site Greer South Carolina 29651 —
GSK Investigational Site Simpsonville South Carolina 29681 —
GSK Investigational Site Spartanburg South Carolina 29303 —
GSK Investigational Site Bristol Tennessee 37620 —
GSK Investigational Site Johnson City Tennessee 37601 —
GSK Investigational Site Kingsport Tennessee 37660 —
GSK Investigational Site Milan Tennessee 38372 —
GSK Investigational Site Morristown Tennessee 37813 —
GSK Investigational Site Corsicana Texas 75110 —
GSK Investigational Site Houston Texas 77024 —
GSK Investigational Site Houston Texas 77030 —
GSK Investigational Site Houston Texas 77074 —
GSK Investigational Site San Antonio Texas 78205 —
GSK Investigational Site San Antonio Texas 78217 —
GSK Investigational Site Salt Lake City Utah 84102 —
GSK Investigational Site Chesapeake Virginia 23320 —
GSK Investigational Site Fredericksburg Virginia 22401 —
GSK Investigational Site Richmond Virginia 23225 —
GSK Investigational Site Richmond Virginia 23249 —
GSK Investigational Site Roanoke Virginia 24016 —
GSK Investigational Site Virginia Beach Virginia 23454 —
GSK Investigational Site Bellingham Washington 98226 —
GSK Investigational Site Spokane Washington 99202 —
GSK Investigational Site Spokane Washington 99204 —
GSK Investigational Site Charleston West Virginia 25304 —
GSK Investigational Site Huntington West Virginia 25701-1693 —
GSK Investigational Site La Crosse Wisconsin 54601 —
GSK Investigational Site Madison Wisconsin 53705 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 269 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00268216, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 20, 2017 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00268216 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →